Search for instruments
Immunomedics Inc
Immunomedics Inc is a biopharmaceutical company that specializes in developing innovative therapies for cancer and other serious diseases. Their lead product candidate, sacituzumab govitecan, is a novel antibody-drug conjugate that targets the TROP-2 receptor, overexpressed in many solid tumors. Immunomedics is also developing other antibody-drug conjugates and bi-specific antibodies for cancer and autoimmune diseases. Their mission is to improve patients' lives by commercializing innovative therapies that address unmet medical needs. Headquartered in Morris Plains, New Jersey, Immunomedics operates in the US and Europe.Instrument specification in OANDA
Name
Currency
Symbol
Minimum order value
Ticker
Trading hours
Type
Hours of accepting orders
ISIN
Start trading now with fast account opening.
Sign-up now to trade the most active markets
Open account
Boasting over 20 years in the markets, leading analysis tools and thousands of satisfied clients, OANDA is proud to be an award-winning broker.
Get access to the most active of global markets with thousands of trading instruments at your fingertips, as well leading technical tools to assist in your analysis.
Trade without unnecessary costs and total pricing transparency - OANDA offers zero-commission on major instruments, transparent pricing.
